Why the study?
Does dopamine infusion affect the secretion of atrial natriuretic factor in healthy subjects and patients with congestive heart failure?
Does dopamine infusion affect the secretion of atrial natriuretic factor in healthy subjects and patients with congestive heart failure?
Low-dose dopamine infusion has divergent effects on atrial natriuretic factor secretion, increasing it in healthy subjects while decreasing it in patients with severe congestive heart failure.
Divergent ANF responses to dopamine warrant caution interpreting levels in treated CHF; leaves open clinical relevance and mechanisms.
We evaluated the effects of dopamine (DA) infusion (1.5 micrograms.kg-1.min-1 for 60 min) on secretion of atrial natriuretic factor (ANF) in 10 healthy subjects and 10 patients with congestive heart failure (CHF) (NYHA Classes III and IV). During DA infusion plasma levels of ANF were significantly raised in healthy subjects while the high basal values of ANF in CHF patients were significantly reduced; this trend was also evident for plasma noradrenaline (NA) levels in both groups. Diuresis, natriuresis and glomerular filtration rate were significantly increased while blood pressure, heart rate and central venous pressure remained unchanged in both groups. These findings indicate that DA infusion may affect the release of ANF. Changes in plasma NA concentration suggest that the sympathetic nervous system may be involved in this phenomenon.
No takes yet. Share an insight, caveat, or question.
Fontana et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: